Condition

Antipsychotics (4)

Schizophrenia (2)

Aripiprazole (1)

Brain Metabolism (1)

Cognition (1)

Dopamine Receptor Occupancy (1)

LAI (1)

Long-Acting Injection (1)

Pregnancy (1)

Overall Status

Completed (3)

Not yet recruiting (1)

Phase

n/a (1)

phase 4 (1)

Sponsor

Icahn School of Medicine at Mount Sinai (1)

Korea Otsuka Pharmaceutical Co., Ltd. (1)

Seoul National University Hospital (1)

Taipei Medical University Hospital (1)

Collaborator

Department of Health, Executive Yuan, R.O.C. (Taiwan) (1)

Erasmus Medical Center (1)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)

National Science Council, Taipei, Taiwan (1)

Intervention

abilify maintena (1)

antipsychotics (1)

aripiprazole (1)

no medication (1)

non-antipsychotic medication (1)

Study Documents

Intervention Type

drug (3)

other (1)

Funder Type

Other (3)

Industry (1)

Study Type

Interventional (2)

Observational (2)

antipsychotics

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Maternal And Infant Antipsychotic Study

Not yet recruiting

Antipsychotics
Pregnancy

Antipsychotics
+2 more

(no location specified)

Sep 16, 2023

Schizophrenia, Antipsychotics, Long-Acting Injection Trial in Korea, Republic of (Abilify maintena)

Completed

Schizophrenia
+4 more

Abilify maintena

Chungju, Chungcheongbuk-do, Korea, Republic of
+26 more

Dec 16, 2021

Antipsychotics, Cognition, Brain Metabolism Trial in Seoul (Aripiprazole)

Completed

Antipsychotics
+3 more

Aripiprazole

Seoul, Korea, Republic of

Seoul National University Hospital

Mar 23, 2012

Atypical Antipsychotics-induced Metabolic Disturbances

Completed

Schizophrenia
Antipsychotics

Taipei, Taiwan

Taipei Medical University-Municipal Wan-Fang Hospital

Jul 10, 2009